Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Sélidji Todagbé Agnandji(Centre de Recherche Médicales de Lambaréné), Claire‐Anne Siegrist(University of Geneva)
Cited by 412
Related Papers
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Influence of <i>Mycobacterium</i> <i>bovis</i> Bacillus Calmette-Guerin on Antibody and Cytokine Responses to Human Neonatal Vaccination
|The Journal of Immunology|2002|290
CpG Oligodeoxynucleotides Can Circumvent the Th2 Polarization of Neonatal Responses to Vaccines But May Fail to Fully Redirect Th2 Responses Established by Neonatal Priming
|The Journal of Immunology|1999|160